Evaluation of pemetrexed (Alimta, LY231514) as second line chemotherapy in persistent or recurrent carcinoma of the cervix: A Phase II study of the Gynecologic Oncology Group
- Resource Type
- Article
- Source
- In
Gynecologic Oncology July 2008 110(1):65-70 - Subject
- Language
- ISSN
- 0090-8258